Literature DB >> 9439376

Clinical and genetic evidence for autosomal dominant North Carolina macular dystrophy in a German family.

D Pauleikhoff1, C G Sauer, C R Müller, M Radermacher, A Merz, B H Weber.   

Abstract

PURPOSE: To describe a German family with clinical and genetic evidence of autosomal dominant North Carolina macular dystrophy.
METHODS: Twenty-six individuals from a five-generation family from northern Germany were investigated clinically. In addition, we performed genetic linkage analyses using polymorphic markers from proximal 6q.
RESULTS: The affected family members showed clinical abnormalities consistent with North Carolina macular dystrophy including multiple drusen, choroidal neovascularization in one patient, and geographic atrophy in elderly patients. The DNA analyses demonstrated significant linkage to the North Carolina macular dystrophy locus on chromosome 6q14-q16.2.
CONCLUSION: Our findings provide strong evidence of a German pedigree with an autosomal dominant macular dystrophy manifesting with clinical abnormalities consistent with North Carolina macular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439376     DOI: 10.1016/s0002-9394(14)70842-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis.

Authors:  K W Small
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  North Carolina macular dystrophy: clinicopathologic correlation.

Authors:  K W Small; I Voo; J Flannery; N Udar; B J Glasgow
Journal:  Trans Am Ophthalmol Soc       Date:  2001

3.  Assessment of the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene localised to 6q13-q15 in autosomal dominant Stargardt-like disease (ADSTGD), progressive bifocal chorioretinal atrophy (PBCRA), and North Carolina macular dystrophy (MCDR1).

Authors:  A Gehrig; U Felbor; R E Kelsell; D M Hunt; I H Maumenee; B H Weber
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

4.  North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13.

Authors:  Kent W Small; Adam P DeLuca; S Scott Whitmore; Thomas Rosenberg; Rosemary Silva-Garcia; Nitin Udar; Bernard Puech; Charles A Garcia; Thomas A Rice; Gerald A Fishman; Elise Héon; James C Folk; Luan M Streb; Christine M Haas; Luke A Wiley; Todd E Scheetz; John H Fingert; Robert F Mullins; Budd A Tucker; Edwin M Stone
Journal:  Ophthalmology       Date:  2015-10-24       Impact factor: 12.079

5.  A novel tandem duplication of PRDM13 in a Chinese family with North Carolina macular dystrophy.

Authors:  Shijing Wu; Zhisheng Yuan; Zixi Sun; Tian Zhu; Xing Wei; Xuan Zou; Ruifang Sui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-24       Impact factor: 3.117

6.  A Korean family with an early-onset autosomal dominant macular dystrophy resembling North Carolina macular dystrophy.

Authors:  Sang Jin Kim; Se Joon Woo; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2006-12

7.  Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy.

Authors:  Thomas Rosenberg; Ben Roos; Thorkild Johnsen; Niels Bech; Todd E Scheetz; Michael Larsen; Edwin M Stone; John H Fingert
Journal:  Mol Vis       Date:  2010-12-09       Impact factor: 2.367

8.  Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus.

Authors:  Valentina Cipriani; Raquel S Silva; Gavin Arno; Nikolas Pontikos; Ambreen Kalhoro; Sandra Valeina; Inna Inashkina; Mareta Audere; Katrina Rutka; Bernard Puech; Michel Michaelides; Veronica van Heyningen; Baiba Lace; Andrew R Webster; Anthony T Moore
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

9.  A novel duplication involving PRDM13 in a Turkish family supports its role in North Carolina macular dystrophy (NCMD/MCDR1).

Authors:  Kent W Small; Stijn Van de Sompele; Karen Nuytemans; Andrea Vincent; Ozge Ozalp Yuregir; Emine Ciloglu; Cahfer Sariyildiz; Toon Rosseel; Jessica Avetisjan; Nitin Udar; Jeffery M Vance; Margaret A Pericak-Vance; Elfride De Baere; Fadi S Shaya
Journal:  Mol Vis       Date:  2021-09-01       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.